Psychology & Psychiatry

New theory may explain cause of depression and improve treatments

A new area in depression research suggests dysfunction in mitochondria—the main source of energy for cells—could lead to major depression. Published in Frontiers in Neuroscience, this new insight to long-held theories ...

Psychology & Psychiatry

A tiny molecule may help battle depression

Levels of a small molecule found only in humans and in other primates are lower in the brains of depressed individuals, according to researchers at McGill University and the Douglas Institute. This discovery may hold a key ...

Psychology & Psychiatry

Targeting inflammation to treat depression

Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of ...

Medications

FDA declines to approve Orexigen diet drug

(AP) -- Orexigen Therapeutics Inc. shares plunged nearly 75 percent in pre-market trading Tuesday after U.S. health officials declined to approve the experimental weight loss pill Contrave.

Psychology & Psychiatry

Ketamine cousin rapidly lifts depression without side effects

GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the street drug side effects, reported a study funded by the National Institute of Mental Health (NIMH) that was published last month ...

page 2 from 11